Artículo

Comprehensive retrospect and future perspective on bacteriophage and cancer

Resumen

Background: Researchers gradually focus on the relationship between phage and cancer. Objective: To summarize the research hotspots and trends in the field of bacteriophage and cancer. Methods: The downloaded articles were searched from the Web of Science Core Collection database from January 2008 to June 2023. Bibliometric analysis was carried out through CiteSpace, including the analysis of cooperative networks (country/region, institution, and author), co-citations of references, and key words.Visual analysis of three topics, including gut phage, phage and bacteria, and phage and tumor, was conducted. Results: Overall, the United States and China have the most phage-related research. In terms of gut phage, the future research directions are “gut microbiome”, “database” and “microbiota”. The bursting citations explored the phage-dominated viral genome to discover its diversity and individual specificity and investigated associations among bacteriome, metabolome, and virome. In terms of phage and bacteria, “lipopolysaccharide” and “microbiota” are future research directions. Future research hotspots should mainly concentrate on the further exploration and application of phage properties. As for phages and tumors, the future research directions should be “colorectal cancer”, “protein” and “phage therapy”. Future directions are likely to focus on the research on phages in cancer mechanisms, cancer diagnosis, and cancer treatment combined with genetic engineering techniques. Conclusion: Phage therapy would become a hot spot and research direction of tumor and phage research, and the relationship between phage and tumor, especially colorectal cancer (CRC), is expected to be further explored.
Jiang, Wenshuo (59129847200); Zhao, Zhigang (57190214291)
Trends in research on AI-aided drug discovery from 2009 to 2023: A 15-year bibliometric analysis
2025
10.1016/j.ipha.2024.09.001
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85212061111&doi=10.1016%2fj.ipha.2024.09.001&partnerID=40&md5=b3447fcfd17488160d15f721ea76776d
Department of Pharmacy, Beijing Tiantan Hospital, Capital Medical University, Beijing, China; Department of Clinical Pharmacology, College of Pharmaceutical Sciences, Capital Medical University, Beijing, China
All Open Access; Hybrid Gold Open Access
Scopus
Artículo obtenido de:
Scopus
0 0 votos
Califica el artículo
Subscribirse
Notificación de